Literature DB >> 20024653

Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.

Cedric Manlhiot1, Kyle Millar, Fraser Golding, Brian W McCrindle.   

Abstract

Competing definitions and classifications of coronary artery abnormalities (CAAs) after Kawasaki disease (KD) have been arbitrarily defined based on clinical experience. We sought to propose a classification system for CAAs based only on coronary artery z-scores. All echocardiograms performed between 1990 and 2007 on patients with a previous history of KD were reviewed. Coronary artery luminal dimensions were converted to body-surface-area-adjusted z-scores and compared to current classification systems. A total of 1356 patients with a previous history of KD underwent 4379 echocardiograms. There was important overlap in the distributions of coronary artery z-scores between the different CAA classes as defined by the American Heart Association (AHA). The AHA classification underestimated the severity of CAAs in 19-32% of small CAAs and 35-78% of medium CAAs. We determined the optimal definition of CAA to be small if the z-score is >or=2.5 to <5.0, large if the z-score is >or=5.0 to <10.0, and giant if the z-score is >or=10.0. This classification seems to appropriately apply to the circumflex branch despite a lack of normal values for this branch. The current AHA classification might not accurately classify CAAs in KD patients. Accurate classification is important for defining management and prognosis consistently across patient age and size.

Entities:  

Mesh:

Year:  2009        PMID: 20024653     DOI: 10.1007/s00246-009-9599-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  18 in total

1.  Coronary artery dilatation exceeding 4.0 mm during acute Kawasaki disease predicts a high probability of subsequent late intima-medial thickening.

Authors:  E Tsuda; T Kamiya; K Kimura; Y Ono; S Echigo
Journal:  Pediatr Cardiol       Date:  2002-02-19       Impact factor: 1.655

2.  Kawasaki disease, myocardial infarction and coronary artery revascularization.

Authors:  Derek Wong; Joyce Harder; Taj Jadavji
Journal:  Can J Cardiol       Date:  2005-05-15       Impact factor: 5.223

3.  Reduced shear stress and disturbed flow may lead to coronary aneurysm and thrombus formations.

Authors:  Takashi Ohkubo; Ryuji Fukazawa; Ei Ikegami; Shunichi Ogawa
Journal:  Pediatr Int       Date:  2007-02       Impact factor: 1.524

4.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

5.  Effects of coronary artery aneurysms on intracoronary flow velocity dynamics in Kawasaki disease.

Authors:  K Hamaoka; Z Onouchi
Journal:  Am J Cardiol       Date:  1996-04-15       Impact factor: 2.778

6.  Fate of coronary arterial aneurysms in Kawasaki disease.

Authors:  A Suzuki; T Kamiya; Y Arakaki; Y Kinoshita; K Kimura
Journal:  Am J Cardiol       Date:  1994-10-15       Impact factor: 2.778

7.  Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease.

Authors:  Deborah M Levy; Earl D Silverman; M Patricia Massicotte; Brian W McCrindle; Rae S M Yeung
Journal:  J Rheumatol       Date:  2005-05       Impact factor: 4.666

Review 8.  Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque.

Authors:  C L Feldman; P H Stone
Journal:  Curr Opin Cardiol       Date:  2000-11       Impact factor: 2.161

9.  Outcome of coronary artery aneurysms after Kawasaki disease.

Authors:  T Akagi; V Rose; L N Benson; A Newman; R M Freedom
Journal:  J Pediatr       Date:  1992-11       Impact factor: 4.406

10.  Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease.

Authors:  Nobutaka Noto; Tomoo Okada; Kensuke Karasawa; Mamoru Ayusawa; Naokata Sumitomo; Kensuke Harada; Hideo Mugishima
Journal:  Pediatr Cardiol       Date:  2008-11-20       Impact factor: 1.655

View more
  56 in total

1.  Atypical Kawasaki disease--a clinical challenge.

Authors:  Jonathan Forsey; Luc Mertens
Journal:  Eur J Pediatr       Date:  2011-11-25       Impact factor: 3.183

2.  Myocardial Layers Specific Strain Analysis for the Acute Phase of Infant Kawasaki Disease.

Authors:  Lucy Youngmin Eun; Ji Hong Kim; Jo Won Jung; Jae Young Choi
Journal:  Pediatr Cardiol       Date:  2016-07-09       Impact factor: 1.655

3.  Evolution of laboratory values in patients with Kawasaki disease.

Authors:  Adriana H Tremoulet; Sonia Jain; Divya Chandrasekar; Xiaoying Sun; Yuichiro Sato; Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

4.  Long-term anticoagulation in Kawasaki disease: Initial use of low molecular weight heparin is a viable option for patients with severe coronary artery abnormalities.

Authors:  Cedric Manlhiot; Leonardo R Brandão; Zeeshanefatema Somji; Amy L Chesney; Catherine MacDonald; Rebecca C Gurofsky; Tarun Sabharwal; Nita Chahal; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2010-04-30       Impact factor: 1.655

5.  Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.

Authors:  Yue Peng; Qiongfei Pei; Siqi Feng; Ya Su; Ruixi Liu; Qijian Yi; Pengfei Guo
Journal:  Clin Exp Med       Date:  2019-09-03       Impact factor: 3.984

Review 6.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

7.  The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.

Authors:  Ariane McNeal-Davidson; Anne Fournier; Rosie Scuccimarri; Adrian Dancea; Christine Houde; Marc Bellavance; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2012-06-17       Impact factor: 1.655

Review 8.  Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.

Authors:  Nobutaka Noto; Akiko Komori; Mamoru Ayusawa; Shori Takahashi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

9.  Coronary Diameters in Taiwanese Children Younger than 6 Years Old: Z-Score Regression Equations Derived from Body Surface Area.

Authors:  Ming-Tai Lin; Chin-Hao Chang; Wen-Chin Hsieh; Chi-En Chang; Ya-Mei Chang; Yung-Chuan Chen; Jui-Yu Hsu; Yi-Ling Huang; Juine-Yih Ma; Li-Chuan Sun; Chi-Sen Wu; Su-Zen Yeh; Wei-Quan Fang; Chun-An Chen; Shuenn-Nan Chiu; Chun-Wei Lu; Jou-Kou Wang; Mei-Hwan Wu
Journal:  Acta Cardiol Sin       Date:  2014-07       Impact factor: 2.672

10.  Atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms.

Authors:  Elizabeth Niedra; Nita Chahal; Cedric Manlhiot; Rae S M Yeung; Brian W McCrindle
Journal:  Pediatr Cardiol       Date:  2013-07-18       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.